Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5705_Библиотеки_им_академика_М_И_Перельмана.pdf
308
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
10.5 BIOCERAMIC IN DRUG DELIVERY APPLICATIONS
-
mesoporous silica particles are implanted in bone tissues, a physiological
-
2001). Among the protein delivery, Album has got special attention due to
maintaining osmotic pressure, (ii) maintaining blood pH, and (iii) Revers-
Bioceramics System for Biomedical Application
309
-
-
-
(Wang et al., 2013), methotrexate (Rosenholm et al., 2010), anti-herceptin
(Milgroom et al., 2014) and many more (Fig. 10.3). It has been observed
that tumor mass is having more dense collagen layer outside the mass
-
(Villegas et al., 2015).
310
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
FIGURE 10.3
10.6 DOPED BIOCERAMIC IN BIOMEDICAL APPLICATION
-
3
and MnO
2
-
2+
, Mg
2+
, Mn
2+
,
Co
2+
, Sr
2+
, and Fe
3+
2+
Bioceramics System for Biomedical Application
311
al., 2021). Cerium, terbium, erbium, europium, lanthanum, and dysprosium
et al., 2015).
2+
-
Mg
2+
-doped mesoporous bioactive nanoparticles have been studied incorpo-
or silver nanoparticles has been investigated by many researchers to overcome
-
2+
-
Cu
2+
2+
312
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
as its antibacterial and osteogenic properties are concerned. Sr
2+
then used
related studies on Sr
2+
10.7 CONCLUSIONS
more than ten years. For more than 10 years, BG and several CPC have been
surgery has been to get a positive biological response despite the restric-
several composites and multilayer systems are being developed and tested.
10.8 FUTURE DIRECTION
Bioceramics System for Biomedical Application
313
-
remedying
ACKNOWLEDGMENTS
KEYWORDS
• bioceramics
• orthopedic applications
• maxillofacial surgery
• drug delivery
REFERENCES
Int. J. Biol. Macromol. 2017, 101, 51–58.
J. Baghdad Coll. Dent.
2019,
Applications. J. Mater. Sci. Mater. Med. 2007, 18,
s10856-007-3041-6
Bioactive Glass Implants. J. Oral Maxillofac. Surg. 2001, 59,
314
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Osteoarthr . Cartil. 2006, 14,
Ann. Surg. 1920, 71, 32–39.
Front. Bioeng. Biotechnol.
2016,
J. Tissue
Eng. 2013, 4,
Int. J. Morphol. 2019, 82–86.
Nanostructured Biomaterials for
Regenerative Medicine
B978-0-08-102594-9.00004-8
System. Materials 2019, 12,
Acta Biomater. 2014, 10,
Adv. Funct. Mater. 2014, 24,
Biomater. Sci. 2016, 4, 803–813.
Science 1995, 269,
Front. Bioeng. Biotechnol. 2015, 3.
. Acta Biomater. 2014, 10,
Dent. Mater. 2008,
24,
Bioceramics System for Biomedical Application
315
Materials to Promote Bone Formation. Acta Biomater. 2008, 4,
J. Am. Chem. Soc.
2006, 128,
ACS Appl. Mater. Interfaces
2017, 9,
Mechanisms. Eur. Cell. Mater. 2011, 21,
ecm.v021a31
J.
Am. Chem. Soc. 1992a, 114,
[WWW Document]. ACS Publ.
Mater. Sci. Eng. C Mater. Biol. Appl. 2017, 70,
J.
Eur . Ceram. Soc. 2010, 30,
Compressive Layers. Compos. Sci. T echnol. 2007, 67,
compscitech.2006.10.010
Agents. Adv. Drug Deliv. Rev., 2011, 63,
biological-response-and-blood-plasma-protein-adsorption-silver-doped-hydroxyapatite
(accessed 1.6.23).
J. Oral Maxillofac. Surg., Interdiscip. Adv.
Implant Dent. 2009, 67,
Bohner, M. Calcium Orthophosphates in Medicine: From Ceramics to Calcium Phosphate
Cements. Injury 2000, 31,
and Hopes. J. Eur. Ceram. Soc., 2012, 32,
316
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Nat. Mater. 2014, 13,
Surg. 2016, 44,
Compos. Part Appl. Sci. Manuf. 2009, 40,
Advances in Protein Chemistry,
Lipoproteins, Apolipoproteins, and Lipases
S0065-3233(08)60640-3
Devices Based on Mesoporous Silicate. Drug Deliv. 2004, 11,
Salicylic Acid: An In Vitro Study. Biomacromolecules 2014, 15,
J.
Mater. Chem. B 2013, 1,
Unique Structure. Nat. Mater. 2003, 2,
J.
Phys. Chem. A 2003, 107,
J. Eur. Ceram. Soc., 2009, 29,
J. Am. Ceram. Soc. 2009,
92,
Int. J. Oral
Maxillofac. Surg. 2009, 38,
Biomaterials
2002, 23,
Int. J. Nanomed. 2008, 3, 403–414.
IRBM,
Numéro Spécial - RITS 2013, 34,
Bioceramics System for Biomedical Application
317
Generated Extracellular Matrix and Fluid Shear Stress Synergistically Enhance 3D
Proc. Natl. Acad. Sci. U. S. A. 2006, 103,
OH, 2003.
J. Mater. Sci. 2020, 55,
s10853-020-04644-0
Protein Adsorption onto Mesoporous Silicates. J. Phys. Chem. B 2002, 106, 7340–7347.
Morphogenetic Protein 2. J. Biomed. Mater. Res. A 2006, 76,
Biomed. Mater. Eng. 2002, 12, 15–35.
and Future Directions. BMC Med. 2011a, 9,
and Future Directions. BMC Med. 2011b, 9,
J. Mater. Chem. 2006, 16,
Materials 2019,
12,
Biomedical Applications. Ceram. Int. 2016, 42,
ceramint.2016.01.062
J. Mater. Sci. Mater. Med. 2013, 24,
2009a, 2,
2009b, 2,
Mg2+ or Mn2+ Ion. Compos. Part B Eng. 2020, 190,
compositesb.2020.107937
Applications. J. Am. Ceram. Soc. 2013, 96,